Concourse Financial Group Securities, Inc. Acurx Pharmaceuticals, Inc. Put Options Transaction History

Concourse Financial Group Securities, Inc.

  • $0
  • Q2 2025

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding ACXP

# of Institutions
6
Shares Held
36.4K
Call Options Held
100
Put Options Held
0
View Full List

About Acurx Pharmaceuticals, Inc.

ACXP Quotes by TradingView
  • Ticker ACXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,556,600
  • Market Cap $48.8M
  • Description
  • Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...
More about ACXP
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email